RCS - Intnl. Biotechnology - Latest Factsheet and Blog

International Biotechnology TrustAnnouncement

Tue 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250527:nRSa0388Ka&default-theme=true

RNS Number : 0388K  Intl. Biotechnology Trust PLC  27 May 2025

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 30 April 2025 is now available directly
via its web page. Please click here
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
, then 'latest factsheet'.

 

Successful biotech investing isn't just about spotting winners - it's also
about filtering out the likely failures. From dubious clinical data to
overconfident founders, Ailsa Craig and Marek Poszepczynski, IBTs Portfolio
Managers, have seen it all. In their latest blog post, they take a look at
what to expect, with help from the history books.

 

The blog can be read here:
https://www.schroders.com/en-gb/uk/individual/content/spotting-the-red-flags-the-biotech-risks-we-avoid/
(https://www.schroders.com/en-gb/uk/individual/content/spotting-the-red-flags-the-biotech-risks-we-avoid/)

 

To sign up for IBT updates by email, please click here
(https://www.schroders.com/en-gb/uk/individual/never-miss-an-update/) .

 

 

ENDS

 

 

Enquiries:

 

 Schroder Investment Management Limited

 Charlotte Banks (Press)                                                     020 7658 6000

 Kirsty Preston

 Kerry Higgins (Company Secretary)                                           020 7658 6000

 Kaso Legg Communications (Financial PR)

 Charles Gorman                                                              IBT@kl-communications.com (mailto:IBT@kl-communications.com)

 Henry Taylor

 Effie Aye Maung Hider

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAXXLFLEELZBBL